Mycobacterium tuberculosis and nontuberculous mycobacterium multi-gene identification primer group and application thereof

By designing the multi-gene identification primer set and capillary electrophoresis technology, the problems of low positive detection rate and high cost of Mycobacterium tuberculosis and non-tuberculosis detection in the prior art are solved, and efficient and accurate distinction and detection are achieved. Suitable for clinical applications.

CN118957110APending Publication Date: 2024-11-15HUADONG HOSPITAL +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411084902.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-08
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing detection methods for Mycobacterium tuberculosis and Mycobacterium tuberculosis have problems such as low positive detection rate, long cycle, high cost and low specificity, making it difficult to quickly and accurately distinguish the two, especially in clinical practice, resulting in delays in diagnosis and treatment and Difficulty in treatment.

Method used

A multi-gene identification primer set was designed, and multiple PCR was performed through 8 gene-specific primers marked by FAM fluorescent labeling, combined with capillary electrophoresis fragment analysis technology to achieve the detection of 8 target gene loci and internal reference genes simultaneously, which improved the detection sensitivity and Specificity simplifies operational processes and reduces costs.

Benefits of technology

It has achieved efficient and accurate distinction between Mycobacterium tuberculosis and Mycobacterium tuberculosis in a PCR system, which has improved detection efficiency and sensitivity, reduced costs, simplified operations, and is suitable for large-scale promotion and application.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118957110A_ABST
    Figure CN118957110A_ABST
Patent Text Reader

Abstract

The invention discloses a mycobacterium tuberculosis and nontuberculous mycobacterium multi-gene identification primer group and application thereof, and belongs to the technical field of gene detection. The sequences of the primer group are as shown in SEQ ID NO.1-2 and SEQ ID NO.5-18. According to the invention, specific primers of eight genes of a 5 '-end primer are labeled by using FAM fluorescence, so that a reaction system is optimized, simultaneous systematic detection of eight target gene loci in a PCR system is realized, deviation caused by uneven amplification in traditional PCR is overcome, and the detection accuracy is improved. The expression condition of a group of target genes can be accurately and sensitively quantified, the cost is saved, and the efficiency is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of gene detection, and in particular relates to a primer set for multiple gene identification of mycobacterium tuberculosis and non-tuberculous mycobacteria and an application thereof. Background Art

[0002] Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis (MTB) and mainly transmitted through the respiratory tract. TB is a global public health problem that seriously endangers public health. MTB is an acid-fast staining positive bacillus, which was discovered by Koch in TB lesions in 1882. To accelerate the reduction of the incidence of TB, it is crucial to improve the diagnosis rate.

[0003] Nontuberculous mycobacteria (NTM) refers to a group of mycobacteria in the genus Mycobacterium other than MTB and Mycobacterium leprae. They were originally called atypical mycobacteria. Their characteristics are different from MTB, such as being sensitive to acid and alkali; being more tolerant to commonly used anti-TB drugs; and having a growth temperature that is not as strict as that of MTB. They are mostly found in the environment and are conditional pathogens. NTM has attracted attention for causing TB-like lesions, and its antigens overlap with those of MTB. NTM can invade many organs and tissues throughout the body, with the lungs being the most common. NTM can cause chronic lung disease, lymphadenitis, skin and soft tissue infections, and systemic disseminated NTM disease. Common clinical symptoms include cough and fatigue, and those with more severe conditions have fever, which is similar to MTB. In recent years, as the detection rate of NTM has gradually increased, the corresponding awareness of the various diseases caused by it has also gradually increased. Common pathogens include Mycobacterium avium complex, Mycobacterium abscessus, Mycobacterium fortuitum, Mycobacterium kansas, Mycobacterium chelonei, and Mycobacterium Gordon. NTM is very similar to MTB in staining and microscopic morphology, with acid-fast staining in red. Clinical manifestations, signs, and imaging findings are also very similar, and it is impossible to distinguish between NTM and MTB infections. However, NTM is naturally resistant to many anti-flood drugs, and the treatment regimen is completely different from that of MTB, so it is very important to distinguish between MTB and NTM.

[0004] (1) Conventional methods for detecting TB and NTM at home and abroad and their limitations

[0005] 1) Sputum smear acid-fast staining test: The advantages are simplicity, economy, and rapid reference for TB diagnosis. The disadvantages are low detection rate of acid-fast staining microscopy, only about 20%, and a positive microscopy requires at least 5,000 bacteria per milliliter of sputum sample. It cannot distinguish between MTB and NTM, live and dead bacteria, or sensitive and resistant strains.

[0006] 2) Bacterial culture method: The conventional sputum MTB culture method is the gold standard for diagnosing tuberculosis. At the same time, in vitro drug sensitivity tests can be performed. The results of drug sensitivity tests can provide accurate and effective references for clinical anti-tuberculosis treatment and control of bacterial resistance. The disadvantages are high nutritional requirements, low positive detection rate (about 36%), long culture cycle, and high biosafety requirements (need a PII+ biosafety laboratory with negative pressure). MTB culture is divided into traditional solid culture and liquid rapid culture. Solid culture generally takes 4 to 8 weeks to get results. Rapid liquid culture takes 2-4 weeks to culture MTB, but it is easily contaminated by other bacteria and false positive results occur. In short, the MTB culture method has a long cycle and a low positive detection rate, and cannot provide a rapid and accurate etiological basis for the diagnosis and treatment of tuberculosis.

[0007] 3) Immunological method: T-spot uses MTB specific protein as antigen to detect the presence of specific antibodies in serum to diagnose tuberculosis. The advantages are rapid and non-destructive, but the disadvantage is that it is limited by factors such as the specificity of the selected protein and the patient's immune status, and the specificity is relatively low, so it is only used as an auxiliary diagnostic indicator.

[0008] 4) Molecular biology methods: including sequencing, single PCR, nested PCR, linear probes, etc. The advantages are rapidity, high sensitivity, and strong specificity, while the disadvantages are few detection sites, low throughput, and high price.

[0009] (2) Process, cost and limitations of MTB and NTM testing

[0010] Clinically, the MTB and NTM pathogen detection process has many steps, high costs, and long time. The routine detection process and steps of TB pathogens are as follows: ① First, collect sputum or other infected samples from suspected TB patients, such as cerebrospinal fluid, pleural effusion or joint fluid, for smear, acid-fast staining, and microscopic examination; ② Solid or liquid culture; ③ For those with positive routine culture, biochemical identification, serological identification, and in vitro drug sensitivity test are performed. ④ Professional laboratories with conditions can carry out T-spot or GeneXpert MTB-RIF testing. The cost of MTB testing is: 15 yuan for acid-fast staining microscopy, 30 yuan for MTB culture, 600 yuan for immunological detection of T-SPOT, and 600 yuan for GeneXpert MTB / RIF detection.

[0011] Therefore, it is of great clinical significance to develop a multiplex gene detection kit product for TB and NTM identification with high throughput, low cost, high sensitivity and good specificity. Summary of the invention

[0012] One of the purposes of the present invention is to provide a primer set for multiple gene identification of Mycobacterium tuberculosis and non-tuberculous mycobacteria, the nucleotide sequences of the primer set are shown in SEQ ID NOs. 1-2, 5-18.

[0013] A second object of the present invention is to provide a reagent for distinguishing Mycobacterium tuberculosis from non-tuberculous mycobacteria, wherein the reagent contains the above-mentioned primer set.

[0014] Preferably, the reagent also contains primers with nucleotide sequences as shown in SEQ ID NOs. 3-4, 19-20.

[0015] The third object of the present invention is to provide a kit for distinguishing Mycobacterium tuberculosis from non-tuberculous mycobacteria, wherein the kit contains a primer set having the above-mentioned nucleotide sequences as shown in SEQ ID NOs. 1-2 and 5-18.

[0016] Preferably, the kit further comprises primers with nucleotide sequences as shown in SEQ ID NOs. 3-4, 19-20.

[0017] A fourth object of the present invention is to provide a primer set having nucleotide sequences as shown in SEQ ID NOs. 1-2 and 5-18 for use in preparing a product for identifying Mycobacterium tuberculosis and non-tuberculous mycobacteria.

[0018] A fifth object of the present invention is to provide a primer set having nucleotide sequences as shown in SEQ ID NO. 1-20 for use in preparing a product for identifying Mycobacterium tuberculosis and non-tuberculous mycobacteria.

[0019] Preferably, the product is a reagent or a kit.

[0020] More preferably, the method for using the kit is:

[0021] (1) Obtaining DNA from the sample to be tested;

[0022] (2) Using the DNA in step (1) as a template, multiplex PCR is performed using a primer set with nucleotide sequences such as SEQ ID NOs. 1-2 and 5-18 or a primer set with SEQ ID NOs. 1-20.

[0023] Compared with the prior art, the present invention has the following beneficial effects:

[0024] (1) The present invention uses specific primers for 8 genes with FAM fluorescently labeled 5′-end primers to optimize the reaction system, realize the systematic detection of 8 target gene sites in one PCR system, overcome the deviation caused by unequal amplification in traditional PCR, and can accurately and sensitively quantify the expression of a group of target genes, saving costs and improving efficiency;

[0025] (2) In addition to detecting the above-mentioned 8 gene loci at one time, the present invention can also simultaneously detect 1 human internal reference gene locus Hum RNA and 1 system internal reference IC.

[0026] (3) The capillary electrophoresis fragment analysis technology used in the fragment analysis of the kit of the present invention is different from the traditional gel electrophoresis analysis mode, making the PCR result analysis more intuitive, concise, reliable, easy to identify and judge, and more conducive to standardized operation.

[0027] (4) The detection kit of the present invention has a simple structure, convenient operation, low detection cost, high accuracy, good repeatability, and the use conditions can be standardized, which is convenient for large-scale promotion and application. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1 8 kinds of detection results of standard strains in Example 1, wherein A is the detection result of Mycobacterium_avium; B is the detection result of internal reference Hum DNA; C is the detection result of Mycolicibacterium_fortuitum; D is the detection result of Mycobacterium_kansasii; E is the detection result of Mycobacterium_intracellulare; F is the detection result of Mycobacterium_gordonae; G is the detection result of Mycobacterium_tuberculosis; H is the detection result of Mycobacteroides_abscessus; I is the detection result of Mycobacteroides_chelonae; J is the detection result of internal reference gene IC.

[0029] Figure 2 These are the detection results of the 10 target points in Example 1.

[0030] Figure 3 The sensitivity test results of the eight pathogen targets in Example 1, where A is the test result corresponding to 80 copies / uL; B is the test result corresponding to 40 copies / uL; C is the test result corresponding to 20 copies / uL; D is the test result corresponding to 10 copies / uL; E is the test result corresponding to 5 copies / uL; F is the negative control ddH 2The test results of O.

[0031] Figure 4 It is the comparison result of the mixed target and single target detection in Example 1, wherein A is the detection result of Mycobacterium_intracellulare and Mycobacterium_tuberculosis; B is the detection result of Mycobacterium_tuberculosis; C is the detection result of Mycobacterium_intracellulare and Mycobacteroides_chelonae; D is the detection result of Mycobacteroides_chelonae; E is the detection result of Mycobacterium_intracellulare and Mycobacterium_tuberculosis; F is the detection result of Mycobacterium_intracellulare; G is the detection result of Mycobacterium_kansasii and Mycobacterium_tuberculosis; H is the detection result of Mycobacterium_kansasii.

[0032] Figure 1 , 3 , The horizontal axis in 4 is Size (bp) and the vertical axis is Dye Signal (rfu). DETAILED DESCRIPTION

[0033] Example 1

[0034] This embodiment provides a multiplex gene detection kit, which includes RT-PCR Buffer, FastStartTaq Polymeras, template sequences and primers pool.

[0035] Primer design principles: Download the gene sequences of 8 target pathogens from Genebank, use VectorNTI software for multiple sequence alignment, select highly conserved, single-copy specific sequences to design primers, and label the 5′ end of the primers with FAM fluorescent dye. Oligo7 was used to design primers, and sequence alignment was performed at the National Center for Biotechnology Information (NCBI) to prove the specificity of each primer. In addition to the basic principles of PCR primer design, the main design principles of multiple primers in the present invention also include: ① Limit the length of the amplified product fragments of all primers to between 100-400bp, and the difference in the length of the amplified products of different primers is greater than 3bp; ② Try to avoid the formation of dimer structures between different primers; ③ Avoid non-specific amplification of any two primers in each pair of primers and non-paired primers. Primer synthesis was completed by Shanghai Bioengineering Co., Ltd. The sequences of each primer are shown in Table 1.

[0036] Table 1 Target primer sequences and product lengths

[0037]

[0038]

[0039] The steps of using the detection kit of this embodiment include:

[0040] A. Collect samples and extract DNA according to routine experimental methods.

[0041] B. Add the primer pool for identification and semi-quantitative detection and perform multiplex PCR.

[0042] C. Multiple PCR products are subjected to capillary electrophoresis by 3500Dx Genetic Analyzer, and PCR products of different fragment sizes are separated. The universal primer is labeled with FAM fluorescence, so that the PCR product is fluorescently labeled, and the fluorescence intensity value of each PCR fragment can be obtained. The ID-X system software analyzes the peak intensity of the target gene target point and further obtains the relative load of each pathogen.

[0043] The detection kit comprises RT-PCR Buffer, FastStart Taq Polymeras, and primers pool fixed in a paper packaging box.

[0044] Example 2

[0045] The detection kit of Example 1 was used to detect Mycobacterium_tuberculosis and 7 NTM (Mycobacterium_avium, Mycolicibacterium_fortuitum, Mycobacterium_kansasii, Mycobacterium_intracellulare, Mycobacterium_gordonae, Mycobacteroides_abscessus and Mycobacteroides_chelonae), and TB / NTM-HMGS was established. The optimization and verification scheme is as follows:

[0046] 1. Extract the pathogen genome of the standard strain.

[0047] The suspension of 1 TB and 7 NTM standard strains was thoroughly shaken and mixed, and 300uL was pipetted into the bacterial genome rapid extraction kit, and the pathogen genome was extracted using Smart LabAssist (Dot Nano, Taiwan, China). After the concentration was measured by UV spectrophotometer, it was stored at 4°C or -20°C for future use.

[0048] 2. Perform multiple PCR reactions using DNA as a template.

[0049] Using the DNA obtained in the previous step as a template, use FAM-labeled forward and reverse primers to amplify the PCR product. The reaction solution in the same PCR reaction tube is prepared as follows:

[0050] Table 2

[0051]

[0052]

[0053] After the system is prepared, run the following program on the PCR instrument:

[0054] Table 3

[0055]

[0056] 3. Use 3500Dx genetic analyzer to perform capillary electrophoresis, detect FAM fluorescence signals, and perform data analysis.

[0057] Add 9 μL of HiDi and 1 μL of multiplex PCR product to each well of a 96-well sample plate.

[0058] According to the operating manual of the 3500Dx Genetic Analyzer, install the capillaries and gel, put the sample plate into the machine, run the separation program, execute the default 3500Dx analysis method, and finally save the data.

[0059] Further Use ID-X software analyzes the results of capillary electrophoresis, and the PCR product fragments of each gene are different in size. The capillary electrophoresis peak diagram obtained in the experiment is as follows Figure 1 As shown, the abscissa represents the fragment length, and the ordinate represents the peak height.

[0060] 4. TB / NTM-HMGS is specific for all target detection targets

[0061] Specific fluorescent primers for the specific identification genes of 8 target pathogens were designed and optimized, and the standard strains corresponding to the 8 pathogens were detected using TB / NTM-HMGS. The results showed that all targets produced specific peaks at the target position, that is, at the position of ±1.5bp of the amplified product fragment length ( Figure 1 ).

[0062] 5. TB / NTM-HMGS can simultaneously detect 10 target sites in a single multiplex PCR reaction

[0063] The nucleic acids of eight pathogen standard strains and the plasmids of two internal reference genes, Human DNA and IC, were mixed at the same concentration of 100 copies / uL and tested using TB / NTM-HMGS (the reaction system and procedures were the same as Tables 2 and 3) to verify its multiplex detection performance for simultaneous detection of 10 target sites. Figure 2 As shown, the TB / NTM-HMGS system was able to simultaneously amplify eight pathogens and two internal reference genes, and the peak values ​​of each target were all higher than the critical value of 300 rfu.

[0064] 6. TB / NTM-HMGS has high sensitivity in detecting 8 pathogen targets

[0065] The standard strains and strains of 8 pathogens were mixed with negative sputum, and the sputum was gradiently diluted to simulate positive samples to obtain 80 (the concentration of each standard strain and strain in the sample was 80 copies / uL), 40 (the concentration of each standard strain and strain in the sample was 40 copies / uL), 20 (the concentration of each standard strain and strain in the sample was 20 copies / uL), 10 (the concentration of each standard strain and strain in the sample was 10 copies / uL) and 5 copies / uL (the concentration of each standard strain and strain was 5 copies / uL) nucleic acids, which were detected using TB / NTM-HMGS (the reaction system and procedures were the same as Table 2 and Table 3), and each gradient was repeated 20 times. The minimum detection limit was determined by the concentration corresponding to the positive detection rate ≥90% in 20 repeated tests, and the positive detection rate of the next lower concentration in the gradient was <10%. The results showed that the minimum detection limit of each pathogen could reach 10 copies / uL ( Figure 3 ), TB / NTM-HMGS has high sensitivity.

[0066] 7. TB / NTM-HMGS can accurately detect TB / NTM multiple infections in sputum

[0067] There are cases of TB / NTM multiple infections in clinical practice. It is very important to accurately detect TB / NTM multiple infection pathogens in sputum based on TB / NTM-HMGS. Five common infectious pathogens (Mycobacterium_intracellulare, 196bp; Mycobacterium_tuberculosis, 237bp; Mycobacteroides_chelonae, 277bp; Mycobacterium_kansasii, 182bp) were used as nucleic acid templates and mixed with negative sputum in pairs. Among them, the high concentration of nucleic acid in the pairwise mixed nucleic acid was 200 copies / uL and the low concentration of nucleic acid was 50 copies / uL. TB / NTM-HMGS was used to detect them separately (the reaction system and procedure were the same as Table 2 and Table 3) and compare whether there were any differences in the peak positions and signal intensities of the pairwise mixed and single target points. The results are as follows Figure 4 As shown in the figure, the position and signal intensity of the mixed target peak are consistent with those of the single target, so TB / NTM-HMGS is capable of detecting TB / NTM multiple infection pathogens.

[0068] The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.

Claims

1. A primer set for multiple gene identification of Mycobacterium tuberculosis and non-tuberculous mycobacteria, characterized in that: The nucleotide sequences of the primer set are shown in SEQ ID NOs. 1-2 and 5-18.

2. A reagent for distinguishing Mycobacterium tuberculosis from non-tuberculous mycobacteria, characterized in that: The reagent contains the primer set described in claim 1.

3. The reagent according to claim 2, characterized in that The reagent also contains primers with nucleotide sequences as shown in SEQ ID NOs. 3-4 and 19-20.

4. A kit for distinguishing Mycobacterium tuberculosis from non-tuberculous mycobacteria, characterized in that: The kit contains the primer set described in claim 1.

5. The kit according to claim 4, characterized in that The kit also contains primers with nucleotide sequences as shown in SEQ ID NOs. 3-4 and 19-20.

6. Use of the primer set described in claim 1 in preparing a product for identifying Mycobacterium tuberculosis and non-tuberculous mycobacteria.

7. Use of a primer set having nucleotide sequences as shown in SEQ ID NOs. 1-20 in preparing a product for identifying Mycobacterium tuberculosis and non-tuberculous mycobacteria.

8. The use according to claim 6 or 7, characterized in that: The product is a reagent or a kit.

9. The use according to claim 8, characterized in that: The method of using the kit is as follows: (1) Obtaining DNA from the sample to be tested; (2) Using the DNA in step (1) as a template, multiplex PCR is performed using a primer set with nucleotide sequences such as SEQ ID NOs. 1-2 and 5-18 or a primer set with SEQ ID NOs. 1-20.